1:59 am Amgen reports new detailed data from three Phase 3 pivotal studies show investigational cholesterol-lowering medicine Evolocumab significantly reduced LDL cholesterol By 55-66%
View todays social media effects on AMGN
View the latest stocks trending across Twitter. Click to view dashboard
See who Amgen is hiring next, click here to view
